Paul Sax, MD, explores the new FDA approval in his blog HIV and ID Observations.
Why did the FDA approve a generic coformulation of AZT/3TC instead of 3TC on its own, as many HIV providers expected? Paul Sax, MD, shares his thoughts in his blog HIV and ID Observations.